Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Samer Al Hadidi

Concepts (185)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
41
2025
2990
7.680
Why?
Hematologic Neoplasms
6
2025
99
3.200
Why?
Immunotherapy, Adoptive
10
2025
161
2.960
Why?
Hematopoietic Stem Cell Transplantation
8
2025
580
2.720
Why?
Antibodies, Bispecific
6
2025
88
2.690
Why?
Hematology
4
2025
27
2.580
Why?
Medical Oncology
6
2024
97
2.430
Why?
Clinical Trials as Topic
7
2025
488
2.400
Why?
Neoplasms
8
2024
1248
2.380
Why?
Hodgkin Disease
3
2021
45
2.040
Why?
Humans
75
2025
50419
1.910
Why?
Drug Approval
5
2024
47
1.890
Why?
Neoplasm Recurrence, Local
6
2024
622
1.870
Why?
Neutropenia
2
2023
116
1.530
Why?
Waldenstrom Macroglobulinemia
2
2022
40
1.480
Why?
Physicians
3
2024
235
1.460
Why?
Transplantation, Autologous
7
2024
480
1.390
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
997
1.270
Why?
T-Lymphocytes
6
2024
325
1.250
Why?
Neoplasms, Second Primary
2
2024
74
1.060
Why?
Neoplasms, Plasma Cell
2
2024
36
1.030
Why?
Cross-Sectional Studies
8
2024
1601
1.010
Why?
United States Food and Drug Administration
6
2024
91
0.980
Why?
United States
14
2025
5005
0.960
Why?
Receptors, G-Protein-Coupled
2
2024
49
0.920
Why?
Authorship
1
2024
12
0.890
Why?
Terminology as Topic
2
2025
67
0.890
Why?
Autoimmune Diseases
1
2025
78
0.880
Why?
Practice Guidelines as Topic
2
2025
473
0.870
Why?
Ubiquitin-Protein Ligases
1
2024
93
0.850
Why?
Antibodies, Monoclonal, Humanized
3
2023
224
0.840
Why?
Awards and Prizes
1
2023
18
0.810
Why?
Fractures, Spontaneous
1
2022
14
0.790
Why?
Tomography, X-Ray Computed
3
2017
1163
0.790
Why?
Thalidomide
1
2024
375
0.770
Why?
Periodicals as Topic
1
2022
58
0.770
Why?
Lymphoma, B-Cell
1
2022
49
0.750
Why?
Bone Diseases
1
2022
96
0.730
Why?
Patient Participation
1
2022
73
0.730
Why?
Venous Thromboembolism
1
2022
74
0.720
Why?
Antibodies, Monoclonal
3
2024
460
0.710
Why?
Brain Diseases
1
2021
83
0.710
Why?
Programmed Cell Death 1 Receptor
1
2020
37
0.690
Why?
Racism
1
2021
60
0.650
Why?
Atrial Fibrillation
1
2022
188
0.650
Why?
Quality of Life
2
2022
850
0.630
Why?
Healthcare Disparities
1
2022
280
0.610
Why?
Receptors, Antigen, T-Cell
3
2024
49
0.610
Why?
Platinum Compounds
1
2018
11
0.590
Why?
Mycosis Fungoides
1
2018
27
0.580
Why?
Subclavian Artery
1
2017
19
0.570
Why?
Pregnancy Complications, Neoplastic
1
2018
23
0.570
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2017
9
0.570
Why?
Antithrombin III Deficiency
1
2017
2
0.570
Why?
Pruritus
1
2018
43
0.570
Why?
Ulcer
1
2017
23
0.550
Why?
Lymphoproliferative Disorders
1
2017
26
0.550
Why?
Epstein-Barr Virus Infections
1
2017
30
0.550
Why?
Tachycardia, Ventricular
1
2017
43
0.550
Why?
Female
14
2025
27053
0.550
Why?
Combined Modality Therapy
4
2024
640
0.540
Why?
Abdominal Pain
1
2017
82
0.540
Why?
Thromboembolism
1
2017
54
0.540
Why?
Colon
1
2017
95
0.540
Why?
Deglutition Disorders
1
2017
77
0.530
Why?
Diagnosis, Differential
5
2018
1029
0.520
Why?
Dexamethasone
3
2024
431
0.510
Why?
Gangrene
1
2016
14
0.510
Why?
Carcinoma, Non-Small-Cell Lung
1
2018
153
0.500
Why?
Penile Diseases
1
2016
16
0.500
Why?
Immunosuppressive Agents
1
2017
227
0.500
Why?
Adult
10
2025
13561
0.490
Why?
Aspirin
1
2016
112
0.480
Why?
Leiomyoma
1
2015
24
0.480
Why?
Migraine with Aura
1
2014
4
0.470
Why?
Hysterectomy
1
2015
88
0.460
Why?
Edema
1
2015
69
0.450
Why?
Early Diagnosis
1
2014
87
0.450
Why?
Carotid Stenosis
1
2014
63
0.450
Why?
Ovarian Neoplasms
1
2018
449
0.440
Why?
Melphalan
3
2023
177
0.410
Why?
Brain Ischemia
1
2014
163
0.410
Why?
Risk Factors
5
2025
3712
0.400
Why?
Skin Neoplasms
1
2018
492
0.400
Why?
Immunotherapy
2
2025
234
0.400
Why?
Middle Aged
7
2025
12579
0.400
Why?
Renal Insufficiency, Chronic
1
2015
173
0.390
Why?
Antineoplastic Agents
1
2020
1165
0.390
Why?
Monoclonal Gammopathy of Undetermined Significance
2
2023
112
0.380
Why?
Lung Neoplasms
1
2018
597
0.380
Why?
Myeloid Differentiation Factor 88
2
2022
32
0.380
Why?
Treatment Outcome
5
2025
5265
0.350
Why?
Randomized Controlled Trials as Topic
4
2023
567
0.340
Why?
B-Cell Maturation Antigen
4
2024
98
0.340
Why?
Diabetes Mellitus, Type 2
1
2016
515
0.330
Why?
Stroke
1
2014
495
0.320
Why?
Male
7
2025
25866
0.310
Why?
Prognosis
3
2024
1974
0.310
Why?
Survival Analysis
2
2023
658
0.310
Why?
Breast Neoplasms
1
2018
1198
0.300
Why?
Conflict of Interest
2
2024
25
0.280
Why?
Pulmonary Emphysema
1
2017
24
0.280
Why?
Drug Resistance, Neoplasm
2
2020
315
0.270
Why?
Tumor Microenvironment
3
2023
221
0.270
Why?
Mutation
2
2022
1275
0.250
Why?
Plasma Cells
2
2024
220
0.250
Why?
Syndrome
2
2021
236
0.240
Why?
Career Choice
2
2024
112
0.240
Why?
Phthalimides
1
2024
3
0.230
Why?
Piperidones
1
2024
6
0.230
Why?
Drug Industry
1
2024
38
0.220
Why?
Morpholines
1
2024
64
0.220
Why?
Disease Management
1
2025
179
0.210
Why?
Adaptor Proteins, Signal Transducing
1
2024
200
0.210
Why?
Molecular Targeted Therapy
1
2024
122
0.210
Why?
Neoplasm, Residual
2
2022
161
0.210
Why?
Financing, Organized
1
2023
13
0.210
Why?
Fellowships and Scholarships
1
2024
120
0.210
Why?
Societies, Medical
1
2024
189
0.210
Why?
Health Facilities
1
2023
39
0.200
Why?
Faculty
1
2022
71
0.200
Why?
Certification
1
2022
50
0.200
Why?
Patients
1
2022
49
0.200
Why?
Geography
1
2022
60
0.200
Why?
Social Media
1
2024
99
0.200
Why?
Animals
4
2024
13063
0.200
Why?
Paraproteinemias
1
2022
71
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Blood Coagulation
1
2022
59
0.190
Why?
Patient Selection
1
2023
257
0.190
Why?
Transplantation Conditioning
1
2022
88
0.190
Why?
Research Design
1
2023
348
0.180
Why?
Phenylalanine
1
2022
134
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
82
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
90
0.180
Why?
Pyrimidines
1
2022
187
0.180
Why?
Maintenance Chemotherapy
1
2020
48
0.170
Why?
Protein Kinase Inhibitors
1
2022
204
0.170
Why?
Risk Assessment
1
2025
1268
0.170
Why?
Pain
1
2022
386
0.160
Why?
Disease Progression
2
2023
825
0.160
Why?
Health Status Disparities
1
2022
201
0.160
Why?
Anticoagulants
1
2022
254
0.160
Why?
Minority Groups
1
2020
130
0.160
Why?
Aged
2
2024
9738
0.150
Why?
Follow-Up Studies
1
2024
2231
0.150
Why?
Chemotherapy, Adjuvant
1
2018
119
0.140
Why?
Prospective Studies
1
2023
2378
0.140
Why?
Vomiting
1
2017
71
0.140
Why?
Electrocardiography
1
2017
266
0.120
Why?
Weight Loss
1
2017
245
0.120
Why?
Carotid Artery, Internal
1
2014
23
0.120
Why?
Endarterectomy, Carotid
1
2014
62
0.110
Why?
Cerebral Angiography
1
2014
97
0.110
Why?
Lower Extremity
1
2015
92
0.110
Why?
Aged, 80 and over
1
2020
3233
0.100
Why?
Pregnancy
1
2018
2444
0.090
Why?
Bone Marrow
2
2022
360
0.090
Why?
Young Adult
1
2018
4075
0.070
Why?
Radiography, Thoracic
1
2017
67
0.070
Why?
World Health Organization
1
2025
50
0.060
Why?
Equipment and Supplies
1
2024
16
0.060
Why?
Marketing
1
2024
22
0.060
Why?
Consensus
1
2025
159
0.060
Why?
Disclosure
1
2024
39
0.060
Why?
Cystatin M
1
2024
19
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
78
0.050
Why?
Mice
2
2024
5659
0.050
Why?
Antibodies
1
2024
151
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Chromosome Deletion
1
2023
134
0.050
Why?
In Situ Hybridization, Fluorescence
1
2023
231
0.050
Why?
Disease-Free Survival
1
2022
439
0.050
Why?
Pharmaceutical Preparations
1
2022
77
0.050
Why?
Genomics
1
2023
238
0.050
Why?
Chromosome Aberrations
1
2023
279
0.050
Why?
Proportional Hazards Models
1
2022
416
0.050
Why?
Bone Marrow Transplantation
1
2022
135
0.050
Why?
Stem Cell Transplantation
1
2022
179
0.040
Why?
Proteasome Inhibitors
1
2021
104
0.040
Why?
Cell Line, Tumor
1
2023
1393
0.040
Why?
Cohort Studies
1
2023
1451
0.040
Why?
Recurrence
1
2021
657
0.040
Why?
Gene Expression Profiling
1
2023
1020
0.040
Why?
Al Hadidi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description